These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38250621)

  • 21. Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput.
    Phan T; Tran NYK; Gottlieb T; Siarakas S; McKew G
    Pathology; 2022 Jun; 54(4):466-471. PubMed ID: 35461715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of reviewing endpoint analysis for negative results on the Xpert Xpress Flu/RSV.
    Matic N; Ritchie G; Lawson T; Karakas L; Romney MG; Lowe CF
    J Med Virol; 2020 Dec; 92(12):3839-3842. PubMed ID: 32249955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.
    Cohen DM; Kline J; May LS; Harnett GE; Gibson J; Liang SY; Rafique Z; Rodriguez CA; McGann KM; Gaydos CA; Mayne D; Phillips D; Cohen J
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses.
    Ling L; Kaplan SE; Lopez JC; Stiles J; Lu X; Tang YW
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the cobas Liat detection test for SARS-CoV-2 and influenza viruses following the emergence of the SARS-CoV-2 Omicron variant.
    Park K; Sung H; Kim MN
    Diagn Microbiol Infect Dis; 2023 Apr; 105(4):115891. PubMed ID: 36738537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children.
    Kanwar N; Michael J; Doran K; Montgomery E; Selvarangan R
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31941689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults.
    Zuurbier RP; Korsten K; Verheij TJM; Butler C; Adriaenssens N; Coenen S; Gruselle O; Vantomme V; van Houten MA; Bont LJ; Wildenbeest JG;
    J Infect Dis; 2022 Aug; 226(Suppl 1):S63-S70. PubMed ID: 35134954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays.
    Quinton M; Geahr M; Gluck L; Jarrett J; Mostafa HH
    J Clin Virol; 2022 Jun; 150-151():105164. PubMed ID: 35468544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Accuracy of the LabTurbo QuadAIO Common Flu Assay for Detecting Influenza A Virus, Influenza B Virus, RSV, and SARS-CoV-2.
    Tai CS; Jian MJ; Lin TH; Chung HY; Chang CK; Perng CL; Hsieh PS; Shang HS
    Diagnostics (Basel); 2024 Oct; 14(19):. PubMed ID: 39410604
    [No Abstract]   [Full Text] [Related]  

  • 31. Multi-center clinical evaluation of the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay in nasopharyngeal swab specimens from symptomatic individuals.
    Sasidharan A; Selvarangan R; Konrad K; Faron ML; Shakir SM; Hillyard D; McCall RK; McHardy IH; Goldberg DC; Dunn JJ; Greninger AL; Lansang C; Bogh R; Remillard CV
    J Clin Microbiol; 2023 Nov; 61(11):e0082723. PubMed ID: 37902331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex CLIA-waived point-of-care tests for SARS-CoV-2, influenza A and B, ± other respiratory pathogens: A systematic review.
    Bernknopf AC; Koski RR; Konieczny AM; Covyeou JA; Klepser ME
    J Am Pharm Assoc (2003); 2024; 64(4):102090. PubMed ID: 38604476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Cobas Liat SARS-CoV-2 Assay in Comparison with the Laboratory-Developed Real-Time RT-PCR Test.
    Er TK; Chou YC; Chen SY; Huang JW
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Evaluation of Xpert Xpress CoV-2/Flu/RSV
    Chan WS; Wong KP; Yau SK; Wong CY; Chan TC; Hung J; Lai KT; Leung CP; Wang CL; Au CH; Wan TS; Ma ES; Tang BS
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Kaira COVID-19/Flu/RSV Detection Kit for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus: A comparative study with the PowerChek SARS-CoV-2, influenza A&B, RSV Multiplex Real-time PCR Kit.
    Kim TY; Bae GE; Kim JY; Kang M; Jang JH; Huh HJ; Chung DR; Lee NY
    PLoS One; 2022; 17(12):e0278530. PubMed ID: 36516190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of the GeneXpert
    Johnson G; Gregorchuk BSJ; Zubrzycki A; Kolsun K; Meyers AFA; Sandstrom PA; Becker MG
    Can J Microbiol; 2023 Mar; 69(3):146-150. PubMed ID: 36657122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-center evaluation of the cobas
    Gibson J; Schechter-Perkins EM; Mitchell P; Mace S; Tian Y; Williams K; Luo R; Yen-Lieberman B
    J Clin Virol; 2017 Oct; 95():5-9. PubMed ID: 28818691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system.
    Paradis S; Lockamy E; Cooper CK; Young S
    J Clin Virol; 2021 Oct; 143():104946. PubMed ID: 34507269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses.
    Davies S; Boller E; Chase J; Beaubrun A; Miller C; Jensen I
    J Med Econ; 2024; 27(1):430-441. PubMed ID: 38328858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test.
    Johnson G; Zubrzycki A; Henry M; Ranadheera C; Corbett C; Meyers AFA; Sandstrom PA; Becker MG
    J Clin Virol Plus; 2021 Jun; 1(1):100014. PubMed ID: 35262002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.